impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Review

 

Systemic sclerosis: one year in review 2026

1, 2, 3, 4, 5, 6, 7, 8

 

  1. Department of Experimental and Clinical Medicine, University of Florence, Section of Rheumatology, AOU Careggi, Florence, Italy. lepri.gemma@gmail.com
  2. Rheumatology Unit, University of Pisa, Italy.
  3. Rheumatology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  4. Rheumatology Unit, University of Pisa, Italy.
  5. Rheumatology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  6. Rheumatology Unit, University of Pisa, Italy.
  7. Department of Experimental and Clinical Medicine, University of Florence, Section of Rheumatology, AOU Careggi, Florence, Italy.
  8. Rheumatology Unit, University of Pisa, Italy.

CER20154
2026 Vol.44, N°8
PI 1453, PF 1467
Review

Free to view
(click on article PDF icon to read the article)

Received: 20/05/2026
Accepted : 25/07/2026
In Press: 18/08/2026
Published: 18/08/2026

Abstract

Systemic sclerosis (SSc) is a rare, chronic connective tissue disease characterised by a complex and not yet fully understood pathophysiology, leading to a wide spectrum of clinical manifestations. Despite important advances over recent years in elucidating disease mechanisms, improving early recognition, and expanding therapeutic options, SSc continues to represent a major clinical challenge due to its heterogeneity and unpredictable course. Ongoing research efforts are essential to better define disease subsets, identify prognostic markers, and refine treatment strategies. In this context, this annual review provides a critical overview of the most relevant studies published in 2025, with a focus on advances in pathogenesis, organ involvement, therapeutic approaches, and patient outcomes in systemic sclerosis.

Rheumatology Article